Results from research in the therapy of chronic hepatitis C;Ergebnisforschung in der Therapie der chronischen Hepatitis C

Internist

Volumn 37, Issue 12, 1996, Pages 1225-1236

  Niederau, C ^a   Heintges, T ^a   Wenning, M ^a   Erhard, A ^a   Petry, W ^a   Hensel, F ^a   Niederau, Ch M ^a   Haussinger D ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; URSODEOXYCHOLIC ACID;

CHRONIC HEPATITIS; ENZYME ACTIVITY; GENOTYPE; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; REVIEW; SIDE EFFECT; SUBCUTANEOUS DRUG ADMINISTRATION;

COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HEPATITIS C; HEPATITIS, CHRONIC; HUMANS; INTERFERONS; LIVER FUNCTION TESTS; RIBAVIRIN; TREATMENT OUTCOME;

EID: 0029728910     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Friedmann HP, Goldberg JD (1996) Meta-analysis: an introduction and point of view. Hepatology 23: 917-928
2. Heintges T, Mohr L, Niederau C (1994) Epidemiologie und Klinik der chronischen Virushepatitis. DMW 119: 1365-1370
3. Zeuzem S, Roth WK, Hermann G (1995) Virushepatitis C. Z Gastroenterol 33: 117-132
4. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ (1992) The natural history of community acquired hepatitis C in the United States. N Engl J Med 327: 1899-905
5. Tong MJ, El-Farra NS, Reikes AR, Co RL (1995) Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332: 1463-1466
6. Seef LB, Buskell-Bales Z, Wright EC et al. (1992) Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 327: 1906-1911
7. Gane EJ, Portmann BC, Naoumov NV et al. (1996) Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334: 815-820
8. Ruiz J, Sangro B, Cuende J, Beloqui O, Riezu-Boj J, Herrero J, Prieto J (1992) Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology 16: 637-641
9. Kobayashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K (1996) The natural course of chronic hepatitis C: A comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 23: 695-699
10. Martinot-Peignoux M, Marcellin P, Pouteau M et al. (1995) Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 22: 1050-1056
11. Liaw Y-F (1995) Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 22: 1101-1108
12. Parés A, Barrera JM, Caballería J et al. (1990) Hepatitis C virus antibodies in chronic alcoholic patients: Association with severity of liver injury. Hepatology 12: 1295-1299
13. Martin P, Di Bisceglie AM, Kassianides C, Lisker-Melman M, Hoofnagle JH (1988) Rapidly progressive non-A non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 97: 1559-1561
14. Rockstroh JK, Spengler U, Sauerbruch T (1995) Therapie der Virushepatitis bei HIV-Infizierten. Dtsch Med Wochenschr 120: 1705-1708
15. Linnen J, Wages J, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadzyiannis S, Karayiannis P, Fung K, Nakatsuji Y, Shih JW, Young, Piatak M, Hooever C, Fernandez J, Chen S, Zou JC, Morris T, Hyams KC, Ismay S, Lifson JD, Kim JP et al. (1996) Hepatitis G virus (HGV), a new hepatitis virus associated with human hepatitis. Science 271: 505-508
16. Hadzyiannis S, Wages J, Kim JP et al. (1995) Frequency of viraemia with a new hepatitis virus (HGV) in patients with liver disease and in groups at high risk of exposure to blood and blood products. J Hepatol 22:A78
17. Fargion S, Piperno A, Cappellini MD, Samprieto M, Fracanzani AL, Romano R, Caldarelli R et al. (1992) Hepatitis C virus and porpyria cutanea tarda: Evidence of a strong association. Hepatology 16: 1322-1326
18. Niederau C, Fischer R, Pürschel A, Stremmel W, Häussinger D, Strohmeyer G (1996) Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 110: 1107-1119
19. Damen M, Cuypers HTM, Zaaijer HL, Reesink HW, Niesters HGM, Lelie PN (1995) Second international quality control study on an HCV-RNA reference panel (Eurohep 2). J Hepatol 23 [Suppl 1]:91
20. Okamoto H, Kurai K, Okada S et al. (1992) Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology 188: 331-341
21. Simmonds P (1995) Variability of hepatitis C virus. Hepatology 21: 570-583
22. Feray C, Gigou M, Samuel D et al. (1995) Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 108: 1088-1096
23. Reichard O, Glaumann H, Frydén A, Norkrans G et al. (1995) Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment. Hepatology 21: 918-922
24. Poynnard T, Bedossa P, Chevallier M et al. (1995) A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 332: 1457-1462
25. Lin R, Roach E, Zimmermann M, Strasser S, Farrell GC (1995) Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. J Hepatol 23: 487-196
26. Niederau C, Hentges T, Häussinger D (1996) Treatment of hepatitis C with alfa-interferon: an analysis of the literature. Hepatogastroenterology (in press)
27. Heintges T, Niederau C, Mohr L, Hensel F, Häussinger D (1996) Diagnose und Therapie der chronischen Virushepatitis. Z Gastroenterol 34: 159-166
28. Roffi L, Mels C, Antonelli G et al. (1995) Breakthrough during recombination interferon alpha therapy in patients with chronic hepatitis C virus infection: prevalence, etiology, and management. Hepatology 21: 645-649
29. Bacon BR, Farrell G, Benhamou JP et al. (1995) Lymphoblastoid interferon improves long-term response to a six month course of treatment when compared with recombinant interferon alfa 2b: Results of an international trial. Hepatology 22:A181
30. Hollinger FB, Blatt LM, Tong MT et al. (1996) Differential response to treatment with consensus interferon (CIFN) and IFN-/alpha 2b in chronic HCV patients infected with genotype 1a and 1b. Gastroenterology 110:A1213
31. Mizokami M, Lau JYN, Suzuki K, Nakano T, Gojobori T (1994) Differential sensitivity of hepatitis C virus quasispecies to interferon-alpha therapy. J Hepatol 21: 884-886
32. Koizumi K, Enomoto N, Kurosuki M, Murakami T, Izumi N, Murumo F, Sato C (1995) Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 22: 30-35
33. Enomoto N, Sakuma I, Asahina J, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C (1996) Mutations in the nonstructural protein A5 gene and response to interferon in patients with chronic hepatitis virus 1b infection. N Engl J Med 334: 77-81
34. Mauss S, Heintges T, Adams O, Albrecht H, Niederau C, Jablonowski H (1996) Treatment of chronic hepatitis C with interferon α-2b in patients infected with the human immunodeficiency virus. Hepatogastroenterol 42: 528-534
35. Heintges T, Mohr L, Niederau C, Strohmeyer G (1995) Diagnose und Therapie der autoimmunen Hepatitis. Z Gastroenterol 333: 462-467
36. Niederau C, Heintges T, Lange S, Goldmann G, Niederau CM, Mohr L, Häussinger D (1996) Long-term follow-up of HBeAig-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 334: 1422-1427
37. Nishiguchi S, Kuroki T, Morimoto H et al. (1995) Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 346: 1051-1055
38. Mazzella G, Accogli E, Sottili S et al. (1996) Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. J Hepatol 24: 141-147
39. Brillanti S, Garson J, Foli M et al. (1994) A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology 107: 812-817
40. Gumber SC, Chopra S (1995) Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1233: 615-620